A Patient-Managed Dual-Product Dressing Strategy Post Mohs Surgery: Collagen–Mānuka Honey–Hydroxyapatite with Silicone Bordered SAP Dressing: Case Report

Rachel Beem; Isaac Rodriguez; Chrystalbelle Rogers; Gwen Beard

doi:10.58372/2835-6276.1373

Authors

Rachel Beem
Isaac Rodriguez
Chrystalbelle Rogers
Gwen Beard

DOI:

https://doi.org/10.58372/2835-6276.1373

Abstract

Postoperative wounds following Mohs micrographic surgery (MMS) can present healing challenges when managed by secondary intention healing (SIH). Conventional SIH care typically involves petrolatum-based dressings and gauze and may be associated with prolonged healing and variable outcomes. This case series evaluates an advanced, patient-managed SIH approach using a bioengineered collagen–Mānuka honey–hydroxyapatite primary dressing (CHD) combined with a silicone bordered SAP (superabsorbent polymer) cover dressing. Nine post-MMS wounds were treated using the dual-dressing regimen delivered via a durable medical equipment (DME) model and applied by patients at home. Healing progression was assessed through serial clinical observation and photography. All wounds demonstrated consistent improvement, including robust granulation tissue formation, re-volumization of tissue defects within an average of six weeks, and reduction in periwound erythema. Patients successfully managed dressing changes independently. This reimbursable, home-delivered dual-dressing strategy may support effective secondary intention healing following MMS while improving access to advanced wound care and patient participation in the healing process.

References

Schwartzman G, Cartron AM, Khachemoune A. Review and reappraisal of assessment parameters of second intention healing after Mohs micrographic surgery. Arch Dermatol Res. 2022 Jan;314(1):17-23.

Rodríguez I, Alvarez A, Massey C, et al. Novel bioengineered collagen with Manuka honey and hydroxyapatite sheet for treatment of lower extremity chronic wounds in an urban hospital wound care setting. Wounds. 2023;35(1):E35-E38.

Rodriguez IA, Strombergsson A, Weinstein R, et al. Preliminary clinical evaluation using a novel bioengineered wound product to treat lower extremity ulcers. Int J Low Extrem Wounds. 2023;22(1):139-145.

McMurray SL, Wallace MM, Stebbins WG, Clayton AS. Use of a novel biomaterial to enhance secondary intention healing. Dermatol Surg. 2021;47(6):843-844.

Arnaud K, Wallace MM, Wheless LE, Stebbins WG, Clayton AS. Novel biomaterial containing gelatin, Manuka honey, and hydroxyapatite enhanced secondary intention healing versus standard secondary intention healing in Mohs surgical defects: randomized controlled trial. Dermatol Surg. 2023;49(12):1160-1164.

Beem R, Rodriguez I, Dhir N, Dhir A, Faust E. At-home use of collagen–mānuka honey–hydroxyapatite dressing for traumatic wound care: A preliminary three-patient case series. Int J Clin Case Rep Rev. 2025;30(5).

Adewumi, T., Ohaji, C., Rodriguez, I., & Wallace, M. (2025). Surgical wound re-volumization through patient-applied collagen–mānuka honey dressing in post-Mohs wound care. Dermatologic Surgery. Advance online publication.

Rodriguez I., Beem, R., Dhir, N., Dhir, A. Wound Healing of Auricular Defects After Mohs Surgery Using an At-Home, Patient-Applied Collagen-Mānuka Honey-Hydroxyapatite Dressing. JOJ Dermatol & Cosmet. 2025; 7(1): 555701.

Williams M, Rodriguez I, Strombergsson A, Fabbri S, Westgate S. A novel bioengineered wound product with in vitro capabilities to reduce bacteria. Biomed Transl Sci. 2021;1(1):1-3.

Rodriguez I, Conti T, Bionda N. Microenvironment influence of a novel bioengineered wound product, APIS®: a preliminary in vitro analysis of inflammatory marker and growth factor secretion. Int J Biomater. 2021;2021:6612870.

Rodriguez I, Conti T, Bionda N. A preliminary direct comparison of the inflammatory reduction and growth factor production capabilities of three commercially available wound products. Int J Mol Sci. 2022;23(18):10670.

Ball, C, Taylor, C, Salgado, B, Révész, E, & Heller, C. (2025). In vitro evaluation of the capability of a silicone superabsorbent polymer (SAP) dressing to modulate pro-inflammatory cytokines. Wounds International, 16(2), 12–23.

Barrett, S, Rippon, MG, and Rogers, AA. (2020). Treatment of 52 patients with a self-adhesive siliconised superabsorbent dressing: a multicentre observational study. Journal of Wound Care, 29(6), 340–349.